Display options
Cite
Habeebu MY, Salako O, Okediji PT, et al. THE DISTRIBUTION, HISTOLOGIC PROFILE AND CLINICAL PRESENTATION OF GASTROINTESTINAL MALIGNANCIES IN LAGOS, NIGERIA. J West Afr Coll Surg. 2017;7(1):9-31
Habeebu, M. Y., Salako, O., Okediji, P. T., Mabadeje, B., Awofeso, O. M., Ajekigbe, A. T., & Abdulkareem, F. B. (2017). THE DISTRIBUTION, HISTOLOGIC PROFILE AND CLINICAL PRESENTATION OF GASTROINTESTINAL MALIGNANCIES IN LAGOS, NIGERIA. Journal of the West African College of Surgeons, 7(1), 9-31.
Habeebu, M Y, et al. "THE DISTRIBUTION, HISTOLOGIC PROFILE AND CLINICAL PRESENTATION OF GASTROINTESTINAL MALIGNANCIES IN LAGOS, NIGERIA." Journal of the West African College of Surgeons vol. 7,1 (2017): 9-31.
Habeebu MY, Salako O, Okediji PT, Mabadeje B, Awofeso OM, Ajekigbe AT, Abdulkareem FB. THE DISTRIBUTION, HISTOLOGIC PROFILE AND CLINICAL PRESENTATION OF GASTROINTESTINAL MALIGNANCIES IN LAGOS, NIGERIA. J West Afr Coll Surg. 2017 Jan-Mar;7(1):9-31. PMID: 29951453; PMCID: PMC6018038.
Copy Download .nbib Format: NLM
Share it on

J West Afr Coll Surg. 2017 Jan-Mar;7(1):9-31.

THE DISTRIBUTION, HISTOLOGIC PROFILE AND CLINICAL PRESENTATION OF GASTROINTESTINAL MALIGNANCIES IN LAGOS, NIGERIA.

Journal of the West African College of Surgeons

M Y Habeebu, O Salako, P T Okediji, B Mabadeje, O M Awofeso, A T Ajekigbe, F B Abdulkareem

Affiliations

  1. Department of Radiotherapy, Lagos University Teaching Hospital, Idi-Araba, Lagos.
  2. Research & Development, Sebeccly Cancer Care, Yaba, Lagos.
  3. College of Medicine, University of Lagos, Idi-Araba, Lagos.
  4. Department of Histopathology, Lagos University Teaching Hospital, Idi-Araba, Lagos.

PMID: 29951453 PMCID: PMC6018038

Abstract

BACKGROUND: Gastrointestinal malignancies have continued to record higher incidence and therefore pose significant public health burden in terms of morbidity and mortality.

AIM: To evaluate the sociodemographic, histologic and clinical distribution of patients with gastrointestinal malignancies diagnosed between July 2009 and March 2016.

SETTING: Lagos University Teaching Hospital, Idi-Araba, south-west Nigeria.

METHODOLOGY: Using a retrospective study design, all the patients with histologic diagnosis of gastrointestinal malignancies were recruited and their bio-data, clinical, histologic and treatment data were extracted from their hospital records.

RESULTS: Of the 106 cases of gastrointestinal malignancies in this study, the age range was 30-82 years with a mean of 55.9±13 years and a peak age bracket of 50-59 years; the male/female ratio was 1.2:1. The most common sites were colorectum (79.3%), stomach (7.6%), anus (6.6%), liver (4.7%), and pancreas (0.9%). Adenocarcinoma was the most common histologic subtype (89.62%), followed by squamous cell carcinoma (2.83%) and gastrointestinal stromal tumors (1.89%). The most common complaints were abdominal pain (54.7%), constipation (38.7%), palpable abdominal swelling/masses (35.9%), bleeding (33.0%), and weight loss (17.0%). The tumors were treated with chemotherapy, surgery, and radiotherapy, either singly or in combination, in 97.2%, 83.0%, and 30.2% respectively.

CONCLUSION: In this study, colorectal cancers are still the most prevalent type of gastrointestinal malignancies with a male preponderance, and individuals between 40-59 years are at greater risk. The significant involvement of individuals who constitute the bulk of the workforce and are the most productive labor in the country points at the need to develop strategies aimed at reducing the incidence of gastrointestinal malignancies.

Keywords: Adenocarcinoma; Colorectal cancers; Gastric cancers; Gastrointestinal malignancies; Nigeria

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

References

  1. Tanzan J Health Res. 2011 Apr;13(2):125-31 - PubMed
  2. Trop Doct. 2005 Apr;35(2):91-2 - PubMed
  3. World J Gastroenterol. 2008 Nov 14;14(42):6531-5 - PubMed
  4. PLoS One. 2012;7(8):e42759 - PubMed
  5. Gastroenterol Hepatol Bed Bench. 2015 Winter;8(1):19-27 - PubMed
  6. Aliment Pharmacol Ther. 2003 Nov;18 Suppl 3:7-30 - PubMed
  7. West Afr J Med. 2009 May;28(3):173-6 - PubMed
  8. Iran Red Crescent Med J. 2011 Nov;13(11):805-10 - PubMed
  9. Trop Doct. 1989 Jul;19(3):135-7 - PubMed
  10. J Trop Med Hyg. 1990 Oct;93(5):351-4 - PubMed
  11. Int J Cancer. 2009 Aug 1;125(3):666-73 - PubMed
  12. East Afr Med J. 1998 Dec;75(12):718-23 - PubMed
  13. West Afr J Med. 2001 Oct-Dec;20(4):251-5 - PubMed
  14. Asian Pac J Cancer Prev. 2009 Jan-Mar;10(1):107-10 - PubMed
  15. Pan Afr Med J. 2010;6:18 - PubMed
  16. Niger J Med. 2003 Oct-Dec;12(4):177-86 - PubMed
  17. Int J Cancer. 2015 Jan 15;136(2):487-90 - PubMed
  18. Trop Geogr Med. 1991 Jan-Apr;43(1-2):189-92 - PubMed
  19. Dis Colon Rectum. 1996 May;39(5):536-40 - PubMed
  20. Niger Postgrad Med J. 2014 Mar;21(1):68-73 - PubMed
  21. Nig Q J Hosp Med. 2010 Apr-Jun;20(2):49-54 - PubMed
  22. Asian Pac J Cancer Prev. 2013;14(12):7587-93 - PubMed
  23. Int J Surg Oncol. 2013;2013:981654 - PubMed
  24. Rare Tumors. 2016 Apr 06;8(1):6183 - PubMed
  25. Saudi Med J. 2000 Aug;21(8):730-4 - PubMed
  26. Cancer Manag Res. 2013 Apr 04;5:31-6 - PubMed
  27. Gastroenterol Clin Biol. 2008 Apr;32(4):430-4 - PubMed
  28. Ghana Med J. 2007 Mar;41(1):12-6 - PubMed
  29. Gastrointest Cancer Res. 2009 Jan;3(1):15-9 - PubMed

Publication Types